“…A promising technological intervention for acrylamide mitigation is represented by asparaginase pre-treatments. Asparaginase is claimed to significantly reduce acrylamide levels by converting asparagine into aspartic acid without altering the appearance and taste of the final product (Capuano et al, 2009;Ciesarová, Kiss, & Boegl, 2006;Ciesarová, Kukurová, Bednáriková, Marková, & Baxa, 2009;Ciesarová, Kukurová, & Benešová, 2010;Hendriksen, Kornbrust, Østergaard, & Stringer, 2006;Kukurová, Morales, Bednáriková, & Ciesarová, 2009;Zyzak et al, 2003). Commercially available asparaginase produced from genetically modified organisms is now permitted for use in the United States, Australia, New Zealand, China, Mexico, Russia, Switzerland, and in several EU countries.…”